Key terms

About HUGE

FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest HUGE news

Apr 22 8:38am ET FSD Pharma Gears Up for unbuzzd™ US Launch by TipRanks Apr 22 8:24am ET FSD Pharma provides update on Celly Nutrition’s launch of unbuzzd by TipRanks Apr 17 8:42am ET FSD Pharma Delves into Weight Loss and Liver Health by TipRanks Apr 17 8:20am ET FSD Pharma expands pipeline to include weight loss, liver health formulations by TipRanks Apr 15 8:47am ET FSD Pharma Increases Stake in Recovery Drink Innovator by TipRanks Apr 15 8:27am ET FSD Pharma provides update on investment in Celly Nutrition by TipRanks Apr 09 5:28pm ET FSD Pharma Faces Nasdaq Compliance Challenge by TipRanks Apr 08 10:07am ET FSD Pharma Faces Nasdaq Compliance Challenge by TipRanks Apr 01 10:37pm ET FSD Pharma Reports Year-End Financials & R&D Progress by TipRanks Mar 27 8:23am ET FSD Pharma partners with iNGENu CRO to conduct Lucid-21-302 study by TipRanks Mar 11 8:47am ET FSD Pharma submits Phase 1b CTA for unbuzzd by TipRanks Mar 11 8:39am ET FSD Pharma Advances Clinical Trial for Innovative Beverage by TipRanks Mar 05 8:40am ET FSD Pharma Unveils Promising MS Drug Trial Results by TipRanks Feb 28 8:47am ET FSD Pharma Settles Debt and Fuels Growth by TipRanks Feb 28 8:19am ET FSD Pharma announces debt settlement by TipRanks Feb 26 8:50am ET FSD Pharma Tests Drink to Quicken Sobriety by TipRanks Feb 26 8:42am ET FSD Pharma enters agreement with Ingenu CRO to conduct unbuzzd trial by TipRanks Feb 06 7:17am ET FSD Pharma says court of appeal dismisses motion for leave to appeal by TipRanks
Apr 07 10:55pm ET FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency by Newsfile

HUGE Financials

1-year income & revenue

Key terms

HUGE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

HUGE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

The logo of Swiss bank UBS is seen at the company's headquarters in Zurich, Switzerland February 10, 2015. REUTERS/Arnd Wiegmann/File Photo
Arnd Wiegmann/Reuters
Switzerland says UBS may need more cash. The bank is fuming
Jamie Dimon, Chairman and Chief Executive officer (CEO) of JPMorgan Chase & Co. (JPM) speaks to the Economic Club of New York in Manhattan in New York City, U.S., April 23, 2024. REUTERS/Mike Segar
Mike Segar/Reuters
Jamie Dimon fears for the future of the free world and US debt
A bubble tea store operated by Sichuan Baicha Baidao in Shanghai, China, on April 23, 2024.
Raul Ariano/Bloomberg/Getty Images
Is the tea bubble bursting? ChaPanda shares plunge in Hong Kong IPO
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Can markets make a comeback? That depends on tech earnings